0001213900-23-047567.txt : 20230608 0001213900-23-047567.hdr.sgml : 20230608 20230608184156 ACCESSION NUMBER: 0001213900-23-047567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230607 FILED AS OF DATE: 20230608 DATE AS OF CHANGE: 20230608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: French Anna Louise CENTRAL INDEX KEY: 0001871871 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39138 FILM NUMBER: 231003341 MAIL ADDRESS: STREET 1: C/O QIMING U.S. HEALTHCARE STREET 2: 11100 NE 8TH ST, SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jasper Therapeutics, Inc. CENTRAL INDEX KEY: 0001788028 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 842984849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 6505491400 MAIL ADDRESS: STREET 1: 2200 BRIDGE PKWY SUITE #102 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp DATE OF NAME CHANGE: 20190912 4 1 ownership.xml X0407 4 2023-06-07 0 0001788028 Jasper Therapeutics, Inc. JSPR 0001871871 French Anna Louise C/O JASPER THERAPEUTICS, INC. 2200 BRIDGE PKWY, SUITE #102 REDWOOD CITY CA 94065 1 0 0 0 0 Stock Option (right to buy) 1.60 2023-06-07 4 A 0 47000 0.00 A 2024-06-07 2033-06-07 Voting Common Stock 47000 47000 D By: /s/ Jeet Mahal, as Attorney-in-Fact 2023-06-08